HealthImmunotherapy Drug Keytruda Halts 'Untreatable' Prostate Cancer In Some Men In a new trial, about 38 percent of prostate cancer patients who used pembrolizumab (Keytruda) were still alive after a year on the treatment. The immunotherapy drug also stopped the tumor growth in 11 percent of patients.by Allan Adamson
HealthA 23-Year-Old Woman Born Without A Vagina Receives One Made Out Of Tilapia Fish Skinby Steven Lerner
HealthIntermittent Fasting Benefits May Also Include Healthier Blood Pressure, On Top Of Weight Lossby Aaron Mamiit
HealthResearchers Say Poop Transplants Are Just As Effective As Antibiotics To Treat C. Difficile Diarrheaby Steven Lerner
HealthWalking At A Faster Pace Is Good For The Heart And Can Help Prevent Premature Deathby Elyse Johnson
HealthTeen Hospitalized With Life-Threatening Illness After 'Too Much' Workout: What Is Rhabdomyolysis?by Athena Chan
HealthThese Genes Might Be Responsible For Our Big Brains, And They’re Only Found In Humansby Carl Velasco